Mediwelcome Healthcare Management & Technology Inc.

SEHK:2159 Stock Report

Market Cap: HK$92.0m

Mediwelcome Healthcare Management & Technology Past Earnings Performance

Past criteria checks 0/6

Mediwelcome Healthcare Management & Technology's earnings have been declining at an average annual rate of -79.8%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been declining at an average rate of 2.9% per year.

Key information

-79.8%

Earnings growth rate

-88.5%

EPS growth rate

Healthcare Industry Growth11.3%
Revenue growth rate-2.9%
Return on equity-80.1%
Net Margin-28.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet

Mar 06
Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet

There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues

Aug 15
There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues

Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively

Aug 12
Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively

Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

Apr 08
Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital

Jan 24
Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital

Revenue & Expenses Breakdown
Beta

How Mediwelcome Healthcare Management & Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:2159 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23331-947933
30 Sep 23315-867839
30 Jun 23298-797644
31 Mar 23311-847848
31 Dec 22323-897951
30 Sep 22432-577544
30 Jun 22541-267138
31 Mar 22625-117028
31 Dec 2170856819
30 Sep 2167166916
30 Jun 2163387013
31 Mar 21533146214
31 Dec 20432215314
30 Sep 20418195015
30 Jun 20404164716
31 Mar 20416184714
31 Dec 19427214712
31 Dec 1829938325
31 Dec 1725930294

Quality Earnings: 2159 is currently unprofitable.

Growing Profit Margin: 2159 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2159 is unprofitable, and losses have increased over the past 5 years at a rate of 79.8% per year.

Accelerating Growth: Unable to compare 2159's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2159 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (13.4%).


Return on Equity

High ROE: 2159 has a negative Return on Equity (-80.1%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.